Don't want ads? Subscribe or login now.

AbbVie Scraps $55B Shire Inversion After Treasury Crackdown

By Karlee Weinmann · October 16, 2014, 8:11 AM EDT

U.S. drugmaker AbbVie Inc. pulled the plug Thursday on its record-setting $55 billion plans to merge with British rival Shire PLC in a controversial inversion deal, a stunning reversal it blamed...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Karlee

January 29, 2015
Icahn-Targeted Manitowoc Agrees To Split Operations
January 29, 2015
January Brings Clarity To Some Of 2014's Buzziest M&A Moves
January 26, 2015
With Irish Court's OK, Medtronic Completes $50B Inversion
January 12, 2015
$2B Steris Inversion Could Be Delayed By Deeper FTC Probe
January 08, 2015
MeadWestvaco Latest To Bow To Activist With Spinoff
January 06, 2015
Investors Cheer $48B Medtronic Deal, Biggest Inversion Yet
January 05, 2015
$48B Medtronic Inversion Faces Blowback As It Heads To Vote
December 22, 2014
The Biggest M&A Moments Of 2014: Second Half
December 10, 2014
Inversions Heating Up Again After Crackdown Froze Deals
December 04, 2014
Chinese Regulators OK $43B Medtronic-Covidien Inversion

AbbVie Scraps $55B Shire Inversion After Treasury Crackdown

Related Sections

Recent Articles By Karlee